Cas No.: 2027476-29-3
PRODUCT INFORMATION
Description
VSLRGDTRG is a synthetic RGD-containing peptide derived from cadherin 17 (CDH17) that binds α2β1 integrin. This binding stimulates its conformational activation, leading to enhanced β1 integrin affinity, FAK/ERK1/2 phosphorylation, and subsequent signaling in CDH17-expressing cell lines. This mechanism involves a CDH17-specific RGD-integrin interaction, which is studied for its role in coordinating dual ligand engagement with collagen IV.
Molecular Weight
960.05
Purity
> 95%
Formula
C₃₈H₆₉N₁₅O₁₄
Product Type
Targeting Peptide
Sequence
Val-Ser-Leu-Arg-Gly-Asp-Thr-Arg-Gly
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- REA Targeting Peptide (CAT#: OLY-1025-YS-66)
- Cyclo(RGDfK(Mal)) Targeting Peptide (CAT#: OLY-1025-YS-46)
- CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- H-Gly-Arg-Gly-Asp-Ser-NH2 Targeting Peptide (CAT#: OLY-1025-YS-15)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.